Markets
BSE See NSE See 27,782.25
-53.66 (-0.19%)
augmentin et grossesse open augmentin et alcool

US FDA’s Alert On Wockhardt: Much Ado About Nothing?

| 5/30/2013 9:02 PM Thursday

Pharma giant Wockhardt has received a strong setback after the US FDA sounded an alert on its Waluj manufacturing facility, after which the stock was hammered by more than 25 per cent in just two trading sessions. The market, however, seems to be overreacting to these developments. Shrikant Akolkar tells us more.

One of the worst things to happen to any stock is for it to get hit by factors which are apparently serious but on deeper exploration seem to be routine. This happens chiefly due to investors’ knee-jerk reaction to news flows which creates humongous negativity around it. One company which has recently been hit by this syndrome is Wockhardt.

We had recommended Wockhardt in DSIJ Vol. 28, Issue # 9 (dated 21 April, 2013) in our cover story ‘Cherry Picking’. The scrip was severely hammered following the recent US FDA alert on its manufacturing facility located in Waluj, Aurangabad district of Maharashtra. In just two trading sessions alone (May 23 and 24, 2013) it lost more than 25 per cent in value. Currently, the stock is down 35 per cent from where we had recommended it. Investors who have acted on our advice would surely be jittery in the wake of such a slide in the stock’s price. What should their future course in this counter be? Should one sell and book losses or wait out the depression? Here are the answers that you would be looking out for.

To start with, the hammering of the stock was a knee-jerk reaction arising out of fears fuelled by a particular event. This fear was accentuated by many other factors that were external to the company. The principal factor among these was the developments in Ranbaxy earlier in the same week.

Ranbaxy, the pharma company now owned by Daichhi Sankyo, pleaded guilty before the United States Department of Justice on compliance related issues in two of its manufacturing facilities. This was in any case weighing heavily on pharma stocks. The alert on Wockhardt’s Waluj facility came immediately after this, and dampened the sentiment on the stock.

What is worth noting is that Ranbaxy had ignored earlier malpractices, the consequences of which it had to bear. Wockhardt, however, had invited the US FDA team to audit its new injectables unit at Waluj. This is what differentiates between the two companies.

Find More Articles on: DSIJ Magazine, Special Report, Stock Recommendations, Fundamental Picks, Product, Large Cap

«« First « Previous |1 2 | Last ››
augmentin et grossesse click augmentin et alcool
symbicort turbuhaler 200 6 cena symbicort 200 cena symbicort 200 cena
collapse Related Readings collapse

DSIJ
Mindshare

augmentin et grossesse open augmentin et alcool
symbicort turbuhaler 200 6 cena symbicort symbicort 200 cena

IT & Pharma Funds under-perform

IT & Pharma Funds  under-perform

Going ahead, investing in Pharma Funds may be a good idea with several analysts being bullish on the sector's growth. Rich valuation may be a limitation when it comes to investing in stocks in Pharma sector.

R Comm and Aircel to buddy up soon

R Comm and Aircel to buddy up soon

Reliance Communications' and Aircel's merger is in the final lap of getting cleared. Reliance Communications which was waiting for a nod from the Department of Telecom (DOT) is now  relieved.

Overnight Digest – Stocks to look out for on August 29

Overnight Digest – Stocks to look out for on August 29

The stocks which could witness a significant movement on August 29 are Capital Trust, Trident, IOC, Alankit and DLF.

Welspun's loss becomes Trident gain

Welspun's loss becomes Trident gain

‘One man’s trash another man’s treasure' is an idiom that somewhat resembles the situation in which Trident is right know sailing. The BSE 500 stock on Aug 26 has emerged as the top gainer on the bourses surging by more than 10 per cent. 

Indices struggled; Tata Motors surges

Indices struggled; Tata Motors surges

The bears have been active from last three consecutive days and the Indian markets are struggling to breakout. In first day of F&O trade, Banking, Healthcare, IT and Capital Goods indices closed on a negative note. The Nifty ended lower by 19 points at 8572; and Sensex was 53 points down at 27782. The indices lost -0.31 to -0.19 per cent respectively.

Tata Motors ends in green despite of weak Q1FY17

Tata Motors ends in green despite of weak Q1FY17

Tata Motors has declared its Q1FY17 results on Friday. The company’s revenue has increased by 9.02 per cent to Rs 67056 crore in Q1FY17 as compared to same period in previous fiscal.

Mid-market commentary Aug 26

Mid-market commentary Aug 26

Indian markets opened on a positive note but retreated from the very moment to trade in red, continuing with its previous fall. Markets have seen gradual lower tops and lower bottoms in the intraday trade. Broader markets are flat.

Abbott India witnesses incremental revenue in Q1FY17

Abbott India witnesses incremental revenue in Q1FY17

Abbott India has declared its Q1FY17 results on Friday. The company’s revenue has increased by 15.83 per cent to Rs 738 crore in Q1FY17 as compared to same period in previous fiscal. 

Top Gainers and Losers of mid-day

Top Gainers and Losers of mid-day

Following are the top gainers and losers list of Aug 26 as on 12.00 pm.  Trident and ICRA are up by double digits’ gainers. Trident has largely rallied on the news that Target Corp is considering to give order of bed sheets to Trident, were as Jaypee Infratech is the largest loser for the day. 

Medicate your portfolio with Pharma stocks

Medicate your portfolio with Pharma stocks

Pharmaceutical industry is a knowledge intensive industry, and faces its own share of challenges.  India is a leading and most favoured supplier of formulations to advanced markets such as US, Europe and semi regulated markets like Africa, LATAM (Latin America).

Subscribe to
Newsletter

news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »

Market
CHIT CHAT

What is your view on markets today?

200  Characters Remaining.
Please LOGIN  to post your comments or Click here to go back.
Anshuman Jena Aug 28 10:33AM
When are the transactios executed ?
debajyoti roy Aug 27 09:58PM
All the Stock return 20% within 1 year
Rohit sharma Aug 27 09:27AM
Sachin Koshti @ 9.15am to 3.30pm Monday to friday
mrinmay sandhyaki Aug 27 03:10AM
oooooonoo
naliniprava mahakul Aug 26 08:53PM
Buy Dishman@174/SL-166/Tgt-194/